Recurrence in Plasmodium vivax malaria: a prospective cohort study with long follow-up from a coastal region in South-West India [version 2; peer review: 2 approved]
Background: India is endemic for Plasmodium vivax (Pv) malaria. Despite a decrease in incidence, its elimination is hampered by recurrences. This study aimed to characterize recurrences in Pv malaria and study its association with primaquine (PQ) usage. Methods: Symptomatic adult Pv patients were...
Main Authors: | Vasudeva Guddattu, Vishnu Teja Nallapati, Divya Gandrala, Alekhya Lavu, Nitin Gupta, Kavitha Saravu |
---|---|
Format: | Article |
Language: | English |
Published: |
F1000 Research Ltd
2022-04-01
|
Series: | F1000Research |
Subjects: | |
Online Access: | https://f1000research.com/articles/11-279/v2 |
Similar Items
-
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
by: Ebstie YA, et al.
Published: (2016-07-01) -
The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
by: Koukeo Phommasone, et al.
Published: (2020-01-01) -
A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India
by: Kavitha Saravu, et al.
Published: (2018-09-01) -
Several Plasmodium vivax relapses after correct primaquine treatment in a patient with impaired cytochrome P450 2D6 function
by: Alexandra Martin Ramírez, et al.
Published: (2020-07-01) -
Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria
by: A. Taylor Bright, et al.
Published: (2013-05-01)